Waeber B, Nussberger J, Brunner H R, de Agostini A, Schapira M
J Hypertens Suppl. 1984 Dec;2(3):S341-2.
The active fragment derived from factor XII (factor XIIf) was purified from human plasma and administered intravenously to normotensive conscious rats. Factor XIIf-mediated hypotension was dose-dependent and augmented by pretreatment with captopril, an inhibitor of the bradykinin-processing enzyme kininase II. These results therefore suggest that factor XIIf-mediated hypotension is due to the formation of bradykinin.
从人血浆中纯化出源自凝血因子 XII 的活性片段(凝血因子 XIIf),并将其静脉注射给血压正常的清醒大鼠。凝血因子 XIIf 介导的低血压具有剂量依赖性,并且用缓激肽加工酶激肽酶 II 的抑制剂卡托普利预处理可增强这种作用。因此,这些结果表明凝血因子 XIIf 介导的低血压是由于缓激肽的形成所致。